Forecasting Clinical Outcomes in Individuals with At-Risk Mental States
Overview
This study identifies predictors of multilevel clinical outcomes in individuals with at-risk mental states (ARMS) using a multimodal framework. Key findings indicate that neurophysiological, clinical, and functional factors can predict future clinical trajectories in ARMS.
Background
Understanding clinical outcomes in ARMS is crucial as these outcomes are heterogeneous and extend beyond simple transition to psychosis. Previous research has largely focused on predicting transitions, neglecting other important stages like remission and persistent symptoms. This study aims to fill that gap by examining multiple outcome stages through integrated neurobiological markers.
Reduced baseline dMMN amplitude is associated with worse clinical outcomes.
Greater severity of attenuated positive symptoms, particularly unusual thought content, correlates with poorer outcomes.
Poor cognitive functioning related to daily living is linked to worse clinical trajectories.
The study utilized a multimodal framework incorporating clinical, functional, and electrophysiological measures.
Clinical outcomes were classified into four categories: remission, symptomatic, prodromal progression, and psychotic.
Clinical Implications
The findings suggest that clinicians should consider a range of neurophysiological and functional factors when assessing individuals with ARMS. Early identification of at-risk individuals may facilitate tailored intervention strategies.
Conclusion
This study highlights the potential for predicting clinical outcomes in ARMS through a multimodal approach, emphasizing the importance of early stratification for personalized care.
